Johnson & Johnson (JNJ) Stock Price, Quote, News & History | Benzinga

Johnson & Johnson (JNJ) Stock Price, Quote, News & History

JNJNYSE

Trade with Public

Trade with Public

$275.23

-3.20-1.15%

At close: Sep 4, 5:00 PM EST

$275.23

N/A

After Hours: 4:15 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Key Statistics

Open

$275.13

Close

$275.23

Volume / Avg.

3.88M / 7.82M

Day Range

$274.75 - $277.80

52 Wk Range

173.33 - 281.07

Market Cap

$663.28B

P/E Ratio

32.30

Dividend Yield

1.93%

Exchange

NYSE

RSI

61

Short Interest

1%

Days to Cover

3.33

Recent Johnson & Johnson News

Johnson & Johnson Secures FDA Approval For First Rare Anemia Treatment

Johnson & Johnson secured FDA approval for IMAAVY, the first targeted therapy to treat warm autoimmune hemolytic anemia in adults and youth.

Vandana Singh

Johnson & Johnson Expands Robotic Bronchoscopy Push With AI, 3D Navigation Upgrade

Johnson & Johnson secures FDA clearance for MONARCH QUEST 3 software, boosting robotic bronchoscopy accuracy with AI. new 3D imaging tools.

Vandana Singh

Cullinan Therapeutics Zipalertinib Combo Clears Key Phase 3 Hurdle As First-Line Lung Cancer Treatment Option Takes Shape

Cullinan Therapeutics and Taiho report positive Phase 3 trial results for zipalertinib in treating advanced lung cancer.

Vandana Singh

Jim Cramer Calls This Industrial Stock ‘Sensational’ And Ameriprise Financial ‘Fantastic’

Jim Cramer praises Lockheed Martin and Ameriprise Financial, advises against Cipher Digital. Eli Lilly to acquire AtaiBeckley for $3.8B.

Avi Kapoor

Kathy Hochul Slams Trump Over Medicare Cut, Says 1.3 Million New Yorkers Will Pay More for Prescriptions: 'A New Assault on Seniors...'

Kathy Hochul says Trump's Medicare subsidy decision will raise prescription drug costs for 1.3 million New Yorkers.

Tanya Rawat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

27.61B

Investing Cash Flow (TTM)

-7.18B

Financing Cash Flow (TTM)

-18.54B

Free Cash Flow (TTM)

22.23B

Capital Expenditure (TTM)

-5.38B

Net Change in Cash (TTM)

1.89B

Analyst Trends and Forecast

1

May

1

Jun

9

1

Jul

2

Aug

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.4

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$699.27B

PE Ratio (TTM)

32.30

PE Ratio (FWD)

21.74

PEG Ratio (TTM)

4.44

PS Ratio (TTM)

6.94

PB Ratio (TTM)

7.90

Earnings Yield % (TTM)

3.10%

Earnings Yield % (FWD)

4.60%

EV / EBITDA (TTM)

20.59

Price / EBITDA (TTM)

20.00

Price / Free Cash Flow (TTM)

30.56

Book Value / Share

$35.26

Company Debt

Total Debt

$49.04B

LT Debt

$37.34B

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

-$3.01B

Total Cash

$20.42B

Debt to Equity

0.58

Issuance of Debt (TTM)

-$3.01B

Repayment of Debt (TTM)

-$19.95B

Key Statistics

Open

$275.13

Close

$275.23

Volume / Avg.

3.88M / 7.82M

Day Range

$274.75 - $277.80

52 Wk Range

173.33 - 281.07

Market Cap

$663.28B

P/E Ratio

32.30

Dividend Yield

1.93%

Exchange

NYSE

RSI

61

Short Interest

1%

Days to Cover

3.33

About

Sector

Health Care

Industry

Pharmaceuticals

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Johnson & Johnson (JNJ) stock?

A

You can purchase shares of Johnson & Johnson (NYSE:JNJ) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Johnson & Johnson (JNJ) competitors?

A

Other companies in Johnson & Johnson’s space includes: Eli Lilly and Co (NYSE:LLY), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS), AstraZeneca PLC (NYSE:AZN) and Novo Nordisk AS (NYSE:NVO).

Q

What is the forecast, or price target, for Johnson & Johnson (JNJ) stock?

A

Johnson & Johnson has a consensus price target of $256.65.

Q

What is the current price for Johnson & Johnson (JNJ)?

A

The stock price for Johnson & Johnson (NYSE: JNJ) is $275.23 last updated September 4, 2026 at 4:15 PM EDT.

Q

Does Johnson & Johnson (JNJ) pay a dividend?

A

There are no upcoming dividends for Johnson & Johnson.

Q

When is Johnson & Johnson (NYSE:JNJ) reporting earnings?

A

Johnson & Johnson does not have any upcoming earnings scheduled.

Q

Is Johnson & Johnson (JNJ) going to split?

A

There is no upcoming split for Johnson & Johnson.

Q

What sector and industry does Johnson & Johnson (JNJ) operate in?

A

Johnson & Johnson is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.